IQE PLC
22 November 2000
IQE plc
IQE ANNOUNCE THE FORMATION OF IQE SILICON COMPOUNDS
IQE plc, the leading outsource supplier of epitaxial
wafers to the Compound Semiconductor Industry, is pleased
to announce today the formation and launch of a newly
created Subsidiary of IQE plc to be named IQE Silicon
Compounds Ltd.
IQE Silicon Compounds will be Europe's first independent
provider of outsourced epitaxial services to the Silicon
based Semiconductor Industry with a range of customer
services from a new facility in Cardiff, Wales, UK. This
operation will be highly complimentary to IQE's existing
compound semiconductor epi wafer products and services
business based on III-V compound substrates, since the
range of epi services now required for the communications
industries is growing rapidly. In particular, newer and
more sophisticated products built on silicon wafers
increasingly require complex epitaxial processes and a
number of new materials such as SiGe are finding wide
spread application, particularly in the fibre optic and
wireless communication industries.
The new Company will supply a flexible, confidential,
secure outsource service commencing in Q1 2001. Services
will include selective and buried layer Si epitaxy for
BiCMOS and Bipolar process; Silicon Germanium (SiGe),
SiGe selective growth and other epi services for
predominantly the fibre optic and wireless communications
industries. All wafers will be supplied with full
performance and characterisation data and wafer sizes of
100mm, 150mm and 200 mm diameters will be catered for.
The first major customer for the new company is Bookham
Technologies plc, who are the leading manufacturer of
optical components and circuits based on Si wafers.
However, there has been exceptional interest shown in the
services to be offered by the new Company, by many other
major European industry players.
IQE Silicon Compounds will operate from a new facility
currently under construction in Cardiff, in close
proximity to IQE's existing operations. Funding for the
operation is predominantly by way of lease finance, aided
by a substantial development grant from the Welsh
Assembly under Regional Selective Assistance of
£1.7million.
Consequently the new Company will not be reliant on
finance raised earlier this year by IQE, which has been
earmarked for growth of its existing Compound
Semiconductor business and for Joint Venture and
Acquisition activity.
Although the new company will leverage strongly from
IQE's existing World leading expertise in epitaxy, a new
team of experts from the Silicon Industry have been
assembled, allowing the new company to grow rapidly
without dilution of management resources of IQE's
existing business.
It is anticipated that operations will commence in Q1
2001 and that the new Company will be close to break even
by 2002. It is expected that over 100 high technology
jobs will be created over the next four years.
Dr Drew Nelson commented 'This development marks another
major step in establishing IQE as the leading provider of
epi services worldwide, with a comprehensive range of
products closely aligned to our customers needs. As the
materials requirements become even more sophisticated to
enable faster, more efficient circuits and components to
be built, epitaxy is becoming ever more important as a
critical step in the manufacturing chain. Our goal is to
provide the highest quality outsource epitaxial wafer
services across the range of materials demanded by the
customer base.'
IQE plc is the leading outsource provider of compound
semiconductor epi wafers with production sites in both
the UK and USA. Its products and services are used by
many major industry players in the optical fibre
communications, wireless communications, optical storage
and consumer products industries.
For further information contact :
IQE plc
Drew Nelson Tel :+44 (0) 292 0839 400
Buchanan Communications
Tim Thompson / Nicola Cronk Tel :+44 (0) 20 7466 5000
Silicon
Alistair Hoy Tel :+44 (0) 292 0362 355
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.